Diseases Market Research Reports

Medical Diseases Market Research Reports, Analysis & Trends

 
Publication Single User License (PDF) Price
LAG-3 Antagonist -Pipeline Insights, 2015

LAG-3 Antagonist -Pipeline Insights, 2015

Date Published: Aug 24 2015
LAG-3 Antagonist- Pipeline Insights, 2015 report provides the in-depth analysis of the pipeline assets across the LAG-3 Antagonist. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The LAG-3 Antagonist Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.
 
$675.00
TIM-3 Antagonist -Pipeline Insights, 2015

TIM-3 Antagonist -Pipeline Insights, 2015

Date Published: Aug 24 2015
TIM-3 Antagonist- Pipeline Insights, 2015 report provides the in-depth analysis of the pipeline assets across the TIM-3 Antagonist. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The TIM-3 Antagonist Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.
 
$575.00
OX-40 Agonist -Pipeline Insights, 2015

OX-40 Agonist -Pipeline Insights, 2015

Date Published: Aug 24 2015
OX-40 Antagonist- Pipeline Insights, 2015 report provides the in-depth analysis of the pipeline assets across the OX-40 Antagonist. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The OX-40 AgonistReport helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.
 
$675.00
Influenza B Infections - Pipeline Review, H2 2015

Influenza B Infections - Pipeline Review, H2 2015

Date Published: Jul 29 2015

Influenza B Infections - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Influenza B Infections - Pipeline Review, H2 2015’, provides an overview of the Influenza B Infections’s therapeutic pipeline.

$2,000.00
Perennial Allergic Rhinitis - Pipeline Review, H2 2015

Perennial Allergic Rhinitis - Pipeline Review, H2 2015

Date Published: Jul 29 2015

Perennial Allergic Rhinitis - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Perennial Allergic Rhinitis - Pipeline Review, H2 2015’, provides an overview of the Perennial Allergic Rhinitis’s therapeutic pipeline.

$2,000.00
Nerve Injury - Pipeline Review, H2 2015

Nerve Injury - Pipeline Review, H2 2015

Date Published: Jul 29 2015

Nerve Injury - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Nerve Injury - Pipeline Review, H2 2015’, provides an overview of the Nerve Injury’s therapeutic pipeline.

$2,000.00
Nasopharyngitis (Common Cold) - Pipeline Review, H2 2015

Nasopharyngitis (Common Cold) - Pipeline Review, H2 2015

Date Published: Jul 29 2015

Nasopharyngitis (Common Cold) - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Nasopharyngitis (Common Cold) - Pipeline Review, H2 2015’, provides an overview of the Nasopharyngitis (Common Cold)’s therapeutic pipeline.

$2,000.00
Botulism - Pipeline Review, H2 2015

Botulism - Pipeline Review, H2 2015

Date Published: Jul 29 2015

Botulism - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Botulism - Pipeline Review, H2 2015’, provides an overview of the Botulism’s therapeutic pipeline.

$2,000.00
Acute Heart Failure - Pipeline Review, H2 2015

Acute Heart Failure - Pipeline Review, H2 2015

Date Published: Jul 29 2015

Acute Heart Failure - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Acute Heart Failure - Pipeline Review, H2 2015’, provides an overview of the Acute Heart Failure’s therapeutic pipeline.

$2,000.00
Rectal Cancer - Pipeline Review, H2 2015

Rectal Cancer - Pipeline Review, H2 2015

Date Published: Jul 29 2015

Rectal Cancer - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Rectal Cancer - Pipeline Review, H2 2015’, provides an overview of the Rectal Cancer’s therapeutic pipeline.

$2,000.00
Otitis Media - Pipeline Review, H2 2015

Otitis Media - Pipeline Review, H2 2015

Date Published: Jul 29 2015

Otitis Media - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Otitis Media - Pipeline Review, H2 2015’, provides an overview of the Otitis Media’s therapeutic pipeline.

$2,000.00
Seasonal Allergic Rhinitis - Pipeline Review, H2 2015

Seasonal Allergic Rhinitis - Pipeline Review, H2 2015

Date Published: Jul 29 2015

Seasonal Allergic Rhinitis - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Seasonal Allergic Rhinitis - Pipeline Review, H2 2015’, provides an overview of the Seasonal Allergic Rhinitis’s therapeutic pipeline.

$2,000.00
Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2015

Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2015

Date Published: Jul 29 2015

Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2015’, provides an overview of the Elephantiasis (Lymphatic Filariasis)’s therapeutic pipeline.

$2,000.00
Eosinophilic Esophagitis - Pipeline Review, H2 2015

Eosinophilic Esophagitis - Pipeline Review, H2 2015

Date Published: Jul 29 2015

Eosinophilic Esophagitis - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Eosinophilic Esophagitis - Pipeline Review, H2 2015’, provides an overview of the Eosinophilic Esophagitis’s therapeutic pipeline.

$2,000.00
Recurrent Malignant Glioma - Pipeline Review, H2 2015

Recurrent Malignant Glioma - Pipeline Review, H2 2015

Date Published: Jul 29 2015

Recurrent Malignant Glioma - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Recurrent Malignant Glioma - Pipeline Review, H2 2015’, provides an overview of the Recurrent Malignant Glioma’s therapeutic pipeline.

$2,000.00
Acute Ischemic Stroke - Pipeline Review, H2 2015

Acute Ischemic Stroke - Pipeline Review, H2 2015

Date Published: Jul 29 2015

Acute Ischemic Stroke - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Acute Ischemic Stroke - Pipeline Review, H2 2015’, provides an overview of the Acute Ischemic Stroke’s therapeutic pipeline.

$2,000.00
Trauma - Pipeline Review, H2 2015

Trauma - Pipeline Review, H2 2015

Date Published: Jul 29 2015

Trauma - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Trauma - Pipeline Review, H2 2015’, provides an overview of the Trauma’s therapeutic pipeline.

$2,000.00
Brain Metastasis - Pipeline Review, H2 2015

Brain Metastasis - Pipeline Review, H2 2015

Date Published: Jul 29 2015

Brain Metastasis - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Brain metastasis - Pipeline Review, H2 2015’, provides an overview of the Brain metastasis’s therapeutic pipeline.

$2,000.00
Biliary Cirrhosis - Pipeline Review, H2 2015

Biliary Cirrhosis - Pipeline Review, H2 2015

Date Published: Jul 29 2015

Biliary Cirrhosis - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Biliary Cirrhosis - Pipeline Review, H2 2015’, provides an overview of the Biliary Cirrhosis’s therapeutic pipeline.

$2,000.00
LAG-3 Antagonists, TIM-3 Antagonists & OX40 Agonists -Pipeline Insights, 2015

LAG-3 Antagonists, TIM-3 Antagonists & OX40 Agonists -Pipeline Insights, 2015

Date Published: Jul 28 2015
DelveInsight’s, LAG-3 Antagonists, TIM-3 Antagonists & OX40 Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the LAG-3 Antagonists, TIM-3 Antagonists & OX40 Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals.
$1,250.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data